CN102885961A - Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine - Google Patents
Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine Download PDFInfo
- Publication number
- CN102885961A CN102885961A CN2011102130129A CN201110213012A CN102885961A CN 102885961 A CN102885961 A CN 102885961A CN 2011102130129 A CN2011102130129 A CN 2011102130129A CN 201110213012 A CN201110213012 A CN 201110213012A CN 102885961 A CN102885961 A CN 102885961A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- parts
- treatment
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine for treating rheumatic arthritis and rheumatoid arthritis and a method for preparing the medicine. The medicine is mainly prepared from pharmaceuticals of polyrhachis vicina roger, zaocys dhumnades, radix aconiti preparata, radix rehmanniae, tripterygium wilfordii, radix clematidis, paniculate swallowwort root, suberect spatholobus stem, herba epimedii, anemarrhena asphodeloides, cornu cervi, buthus martensi karsch, centipede and earthworm, pseudo-ginseng, astragalus, pawpaw, herba taxilli, eucommia ulmoides, radix achyranthis bidentatae, ligusticum chuanxiong and the like. The medicine is used for treating the rheumatoid arthritis and the rheumatic arthritis of finger morning stiffness, muscle and join pain, inhibited bending and stretching, muscle emaciation and anchylosis and malformation, and has the functions of tonifying kidney and strengthening bones, activating blood and relieving wind, dispelling cold and clearing dampness, an exact curative effect and no toxic and side effects.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis, the invention still further relates to the preparation method of this medicine.
Background technology
Arthritis is one of common disease that is detrimental to health, particularly rheumatoid arthritis, and home and overseas has a lot of people inquiring into its cause of disease, seeks the situation that effectively prevention and Therapeutic Method change its prognosis mala.Rheumatoid arthritis is the so far arthritis of not yet sure chronic progressive external of a kind of cause of disease, it has been generally acknowledged that it is a kind of autoimmunity illness, be the result that body defending system is killed each other and caused, heredity, infection, cold wet etc. all may be the factors of causing a disease in addition.Arthritic mainly is synovial membrane inflammation in early days, slides cured hyperemia, swelling, Fibrin exudation is arranged, and forms hydrarthrosis, and typical inflammatory cell infiltration is arranged in the synovial membrane, then involves articular cartilage and osseous tissue, finally causes ankylosis.That ill joint shows as is red, swollen, hot, bitterly and moving obstacle, joint deformity is more and more obvious, patient's rheumatoid factor is often positive, the x-ray inspection has obvious Novel presentation.Doctor trained in Western medicine mainly is oral drug therapy to the treatment of rheumatoid arthritis, and salicylic acid formulation example such as aspirin are drug of first choice, is indometacin, Phenylbutazone and prednisone etc. secondly, to the feasible operative treatment of end-stage patients.Rheumatoid arthritis belongs to " arthromyodynia " scope in motherland's medical science, with the dampness removing collateral dredging, dispelling cold by warming the meridian is main, and prescription commonly used is Radix Angelicae Pubescentis et Herba Taxilli Decoction.Theory of Chinese medical science is thought, the rheumatoid origin cause of formation is mostly because the wet outer ailment said due to cold or exposure of invading, feel again of water, or diseases caused by exogenous pathogenic factor ailment said due to cold or exposure, hold concurrently wet to hold under the arm, so that rheumatism is rich and fall ill mutually, lingers on such as rheumatism and does not go, arthralgia can occur, articular instability, or grain contracture, or the disease such as apathetic, and often with the passing of time delay forms chronic disease.In sum, the disease such as rheumatism, rheumatoid arthritis there is no specific short in treatment.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of the definite and pure Chinese medicinal preparation that has no side effect of rheumatic arthritis, Rheumatoid Arthritis; Another object of the present invention provides the preparation method of this medicine.
Solution of the present invention is to develop according to inventor's years of researches and clinical experience prescription, grope to inquire in the research preparation process, quality standard, assay, stability, pharmacodynamics, curative effect contrast observing etc., form through repeatedly Experiment and clinic presentations screening.
Each raw material components ratio range of medicine of the present invention is:
Formica fusca 10-70 part Zaocys 2-10 part Radix Aconiti Preparata 2-10 part Radix Rehmanniae 2-10 part
Tripterygium hypoglaucum 2-10 part Radix Clematidis 2-10 part Radix Cynanchi Paniculati 2-10 part Caulis Spatholobi 2-10 part
Herba Epimedii 2-10 part Rhizoma Anemarrhenae 2-8 part Cornu Cervi 0.5-5 part Scorpio 2-10 part
Scolopendra 0.5-5 part Pheretima 2-8 part Radix Notoginseng 1-5 part Radix Astragali 2-10 part
Each crude drug weight optimum ratio scope of the present invention is:
Formica fusca 20-60 part Zaocys 3-8 part Radix Aconiti Preparata 3-8 part Radix Rehmanniae 3-8 part
Tripterygium hypoglaucum 3-8 part Radix Clematidis 3-8 part Radix Cynanchi Paniculati 3-8 part Caulis Spatholobi 3-8 part
Herba Epimedii 3-8 part Rhizoma Anemarrhenae 3-7 part Cornu Cervi 0.5-5 part Scorpio 3-8 part
Scolopendra 0.5-5 part Pheretima 3-7 part Radix Notoginseng 1-4 part Radix Astragali 3-8 part
The best proportioning of each crude drug weight of medicine of the present invention is:
Formica fusca 50g Zaocys 6g Radix Aconiti Preparata 4g Radix Rehmanniae 6g
Tripterygium hypoglaucum 6g Radix Clematidis 6g Radix Cynanchi Paniculati 6g Caulis Spatholobi 6g
Herba Epimedii 6g Rhizoma Anemarrhenae 4g Cornu Cervi 1g Scorpio 6g
Scolopendra 1g Pheretima 5g Radix Notoginseng 2g Radix Astragali 6g
Each crude drug weight proportion also comprises:
Fructus Chaenomelis 2-10 part Herba Taxilli 2-10 part Cortex Eucommiae 2-10 part Radix Achyranthis Bidentatae 2-10 part
Rhizoma Chuanxiong 2-10 part
Wherein each crude drug weight optimum ratio is:
Fructus Chaenomelis 3-8 part Herba Taxilli 3-8 part Cortex Eucommiae 3-8 part Radix Achyranthis Bidentatae 3-8 part
Rhizoma Chuanxiong 3-8 part
The best proportioning of each crude drug weight is:
Medicine of the present invention is soft extract or granule or tablet or capsule or pill.
The preparation method of medicine of the present invention: A, animal drugs are ground into coarse powder, soak 1 hour, and the 6-10 times of decocting that adds the medical material amount boils 4 times, each 1 hour; B, plant amedica are ground into coarse powder, soak 1 hour, and the 6-10 times of decocting that adds the medical material amount boils 3 times, each 1 hour; C, merge decoction liquor, be concentrated into the clear paste of relative density 1.08, cooling adds ethanol to containing alcohol amount 55%--75%, stirs, placed 24 hours, and filtration, Recycled ethanol gets thick paste; D, thick paste are made mixture or soft extract or granule or tablet or capsule with sucrose, dextrin, soluble starch.
Another preparation method of medicine of the present invention: A, pulverizing medicinal materials is become fine powder; B, fine powder add refined honey and make honeyed pill or water-honeyed pill, or add water and make the watered pill, or the encapsulated capsule of making of fine powder.
Clinical data
A kind of clinical trial data for the treatment of medicine (be called for short: rheumatism is precious) the treatment numbness sick (rheumatic arthralgia, class are closed scorching) of rheumatic arthritis, rheumatoid arthritis.Random packet is adopted in research,, observes for two courses for the treatment of (one month per course for the treatment of) take YISHEN JUANBI WAN as matched group.Guideline of clinical investigations according to new Chinese medicine treatment numbness disease carries out clinical trial, collects altogether the precious group of rheumatism 100 examples, and the result is as follows:
Name of disease example number clinic control produce effects enabledisable total effective rate
Rheumatic arthralgia 70 15 (21.4%) 20 (28.6%) 34 (48.6%) 1 (1.4%) 98.6%
Class closes scorching 30 9 (30.0%) 9 (30.0%) 11 (36.7%) 1 (3.3%) 96.7%
Add up to 100 24 (24%) 29 (28%) 45 (45%) 2 (2%) 98%
The aggregate efficiency of the precious treatment of rheumatism numbness disease is 98%, and the clinic control rate is 24%, and obvious effective rate is 29%, and effective percentage is 45%, compares with matched group, and analyzing through Ridit has significant difference, and the treatment group curative effect is better than matched group.
Impact on rheumatic arthralgia: treatment group 70 examples, matched group 33 examples are analyzed through Ridit for two groups, have significant difference (p＜0.05), and the treatment group curative effect is better than matched group.
Class is closed scorching impact: each 30 example for the treatment of group and matched group, analyze through Ridit for two groups, have significant difference (p＜0.05), the treatment group curative effect is better than matched group.
Impact on anemofrigid-damp arthralgia and paralysis: analyze through Ridit, compare there was no significant difference (p＜0.05) between treatment group anemofrigid-damp arthralgia and the paralysis, illustrate that this medicine is to the therapeutic equivalence of anemofrigid-damp arthralgia and paralysis.The treatment group of anemofrigid-damp arthralgia and matched group relatively have significant difference (p＜0.01), and the treatment group of paralysis and matched group relatively have significant difference (p＜0.05), and two pattern of syndrome are the treatment group curative effect and are better than matched group.
Impact on erythrocyte sedimentation rate: two groups more all have significant difference (p＜0.01) before and after self, illustrate that two medicines all can obviously reduce erythrocyte sedimentation rate.The comparison there was no significant difference (p＞0.05) of difference before and after between two groups of rheumatic arthralgia, the significant difference (p＜0.05) that relatively has that class is closed scorching two groups of front and back differences illustrates reducing rheumatic arthralgia patient's erythrocyte sedimentation rate, two medicines are without obvious difference, close scorching patient's erythrocyte sedimentation rate to reducing class, curative obviously is better than contrasting medicine.
Class is closed the impact of scorching patient RF, through X
2Check, treatment group and matched group RF negative conversion rate have significant difference (p＜0.01), and treatment group RF negative conversion rate is apparently higher than matched group.
Impact on the clinical symptoms integration: before and after two groups of treatments significant difference (p＜0.01) is arranged more all self, illustrate that two medicines all can obviously improve numbness patient's clinical symptoms.Compare there was no significant difference (p＞0.05) between two groups before the treatment, compare after the treatment between two groups, rheumatic arthralgia group no significant difference (P＞0.05), class is closed scorching group significant difference (p＜0.05), illustrates that the rheumatism treasured more can improve the clinical symptoms that class is closed scorching patient than YISHEN JUANBI WAN.
The precious treatment of rheumatism class is closed scorching, presses functional classification, I, II level patient's curative effect is better than III, IV level patient's curative effect.By by stages, the curative effect of early stage patient is better than middle and advanced stage patient's curative effect, patient's curative effect is better than the curative effect of patients with terminal to mid-term.
In 100 routine treatment groups, only have 1 example the discomfort of having sore throat to occur, dizzy phenomenon appears in 1 example, adheres to that symptom after taking medicine disappears, by analysis, for the probability of drug-induced very little.All the other cases are showed no discomfort.Hematochrome, numeration of leukocyte are improvement after the treatment of the testing data such as routine urinalysis or front and back are normally, hepatic injury also do not occur.As seen, it is safe using the rheumatism treasured.
Model case:
Example 1: Xiong Jicheng, the male, 41 years old, married, peasant, medical hospital: No. 1 Hospital Affiliated to Hunan Traditional Chinese Medical College, first visit time 1994.10.22
Both hands finger and palm joint, interphalangeal joint swelled and ache more than 4 years repeatedly, whenever brought out or increased the weight of because of suffer from cold (groundwater reservoir), once took the medicines such as dipyrone, piroxicam, indometacin, numbness electuary, and the period in a medicine symptom can be controlled, and drug withdrawal is easily recurrence then.Now still feel the both hands finger and palm joint and swell and ache, both hands foods, in, the class fusiformis swelling of nameless joint, moving obstacle, companion's soreness of the waist and knees is tired, pale tongue, white and thin fur, thready and weak pulse.Lab testing: Hb105g/L, WBC6.5 * 10
9/ L N0.28UR: normal, liver function is normal, ESR39mm/h, and RF is positive, and the right hand is slapped positive oblique film: right hand articulations digitorum manus gap turn narrow, osteoporosis, soft tissue is slightly swollen.Suggestion: right hand metacarpophalangeal joints is the rheumatoid sample and changes.
Western medicine diagnose: rheumatoid arthritis
Tcm diagnosis and dialectical: arthromyodynia (paralysis)
Treatment: the precious 500ml of rheumatism * 7 bottles, usage and consumption: each 20ml, every day 3 times, be 1 course for the treatment of January, took continuously for 2 courses for the treatment of.
Curative effect: the rear 4th week of taking medicine end, clinical symptoms is obviously improved, and to rarely seen of the 7th weekend soreness of the waist and knees is arranged, the joint transference cure, body of the tongue is partially red, white and thin fur, small and stringy pulse.
Lab testing check: Hb115g/L, WBC4.5 * 10
9/ L, N0.68 N0.32UR: normal, liver function is normal, ESR18mm/h, RF is negative, X-ray film: be that right hand metacarpophalangeal joints is the rheumatoid sample and changes originally, after treatment check with October 24 photo relatively; Soft tissue swelling disappears, and articulations digitorum manus is slightly clear, and osteoporosis slightly has recovery, and remaining and former roughly the same.
Efficacy evaluation: clinic control
Example 2: patient Liu Manmei, the women, 39 years old, married, the cadre, work unit: Shaoyang City township enterprise administration, medical hospital: Shaoyang Municipal Traditional Chinese Medical Hospital, the first visit time: on JIUYUE 27th, 1994.
The multiple pain in whole body size joint more than 4 years, the postemphasis of whenever suffering from cold once took Radix Tripterygii Wilfordii tablet effective, but often repeatedly outbreak, existing disease is seen: whole body many places size arthralgia, swelling, moving obstacle, numb limbs and tense tendons, tired, emaciated physique, body of the tongue is partially red, white and thin fur, stringy pulse.Look into: body weight 40kg, both hands refer to, the toes joint swelling deformation.Lab testing: Hb90g/L, WBC5.0 * 10
9/ L N0.80 L0.20 urinates 8 normally, epithelial cell 0-2/HP, and ESR38mm/h, RF is positive, the positive bit slice of both hands fingers and palms bone; Both hands metacarpophalangeal joints face is more coarse, and swelling is arranged, and density is lower.Have no obvious destruction sign suggestion, above change meets rheumatoid arthritis and changes.
Western medicine diagnose: rheumatoid arthritis
Tcm diagnosis and dialectical: arthromyodynia (anemofrigid-damp arthralgia)
Treatment: the precious 500ml of rheumatism * 7 bottles, usage and consumption: each 20ml, every day 3 times, took 2 months altogether.
The 3rd all posterior joint pain of taking medicine, tenderness, swelling, moving obstacle obviously alleviates, and to the 8th week rarely seen Chang Guanjie mild pain not, remaining disease disappears, and body of the tongue is light red, white and thin fur, stringy and thready pulse.
Body weight 48kg, lab testing review result: Hb110g/L, WBC6.0 * 10
9/ LN0.75 N0.25 UR is normal, ESR8mm/h, and RF is negative, X-ray film: before be clearly better with the change of 94.9.28 sheet comparison both hands metacarpophalangeal joints.
The specific embodiment
Embodiment one
Take by weighing clean material as follows:
6 parts in 4 parts of Radix Rehmanniae of 6 parts of Radix Aconiti Preparatas of 50 parts of Zaocyss of Formica fusca
6 parts of 6 portions of Caulis Spatholobis of 6 parts of Radix Cynanchi Paniculatis of 6 parts of Radix Clematidis of Tripterygium hypoglaucum
6 parts of 1 portion of Scorpios of 4 parts of Cornu Cervis of 6 parts of Rhizoma Anemarrhenaes of Herba Epimedii
6 parts of 2 parts of Radixs Astragali of 5 portions of Radix Notoginseng of 1 part of Pheretima of Scolopendra
Preparation method is as follows:
A, animal drugs are ground into coarse powder, soak 1 hour, add 6-10 times of decocting of medical material amount and boil each 1 hour 4 times;
B, plant amedica are ground into coarse powder, soak 1 hour, add 6-10 times of decocting of medical material amount and boil each 1 hour 3 times;
C, merge decoction liquor, be concentrated into the clear paste of relative density 1.08, cooling adds ethanol to containing alcohol amount 55%--75%, stirs, placed 24 hours, and filtration, Recycled ethanol gets thick paste;
D, thick paste are made mixture or soft extract or granule or tablet or capsule with sucrose, dextrin, soluble starch.
Embodiment two
Take by weighing raw material with embodiment one, preparation method is as follows:
A, pulverizing medicinal materials is become fine powder;
B, fine powder add refined honey and make honeyed pill or water-honeyed pill, or add water and make the watered pill, or the encapsulated capsule of making of fine powder.
Embodiment 3
Take by weighing clean material as follows:
Preparation method is with embodiment 1
Embodiment 4
Take by weighing raw material with embodiment 3, preparation method is with embodiment 2.
Claims (9)
1. medicine for the treatment of rheumatic arthritis, rheumatoid arthritis is characterized in that it is to be made by the crude drug of following weight proportioning:
Formica fusca 10-70 part Zaocys 2-10 part Radix Aconiti Preparata 2-10 part Radix Rehmanniae 2-10 part
Tripterygium hypoglaucum 2-10 part Radix Clematidis 2-10 part Radix Cynanchi Paniculati 2-10 part Caulis Spatholobi 2-10 part
Herba Epimedii 2-10 part Rhizoma Anemarrhenae 2-8 part Cornu Cervi 0.5-5 part Scorpio 2-10 part
Scolopendra 0.5-5 part Pheretima 2-8 part Radix Notoginseng 1-5 part Radix Astragali 2-10 part.
2. a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis according to claim 1, wherein each crude drug ratio range is:
Formica fusca 20-60 part Zaocys 3-8 part Radix Aconiti Preparata 3-8 part Radix Rehmanniae 3-8 part
Tripterygium hypoglaucum 3-8 part Radix Clematidis 3-8 part Radix Cynanchi Paniculati 3-8 part Caulis Spatholobi 3-8 part
Herba Epimedii 3-8 part Rhizoma Anemarrhenae 3-7 part Cornu Cervi 0.5-5 part Scorpio 3-8 part
Scolopendra 0.5-5 part Pheretima 3-7 part Radix Notoginseng 1-4 part Radix Astragali 3-8 part.
3. a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis according to claim 1, wherein each crude drug weight proportion is:
6 parts in 4 parts of Radix Rehmanniae of 6 parts of Radix Aconiti Preparatas of 50 parts of Zaocyss of Formica fusca
6 parts of 6 portions of Caulis Spatholobis of 6 parts of Radix Cynanchi Paniculatis of 6 parts of Radix Clematidis of Tripterygium hypoglaucum
6 parts of 1 portion of Scorpios of 4 parts of Cornu Cervis of 6 parts of Rhizoma Anemarrhenaes of Herba Epimedii
6 parts of 2 parts of Radixs Astragali of 5 portions of Radix Notoginseng of 1 part of Pheretima of Scolopendra.
4. a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis according to claim 1, wherein each crude drug weight proportion also has:
Fructus Chaenomelis 2-10 part Herba Taxilli 2-10 part Cortex Eucommiae 2-10 part Radix Achyranthis Bidentatae 2-10 part
Rhizoma Chuanxiong 2-10 part.
5. a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis according to claim 4, wherein each crude drug weight proportion is:
Fructus Chaenomelis 3-8 part Herba Taxilli 3-8 part Cortex Eucommiae 3-8 part Radix Achyranthis Bidentatae 3-8 part
Rhizoma Chuanxiong 0-8 part.
6. a kind of medicine for the treatment of rheumatic arthritis, rheumatoid arthritis according to claim 4, wherein each crude drug weight proportion is:
7. according to claim 1,2,3,4,5 or 6 described a kind of medicines for the treatment of rheumatic arthritis, rheumatoid arthritis, it is characterized in that said medicine is soft extract or granule or tablet or capsule or pill.
8. according to claim 1,2,3,4,5,6 or 7 described a kind of preparation methoies for the treatment of the medicine of rheumatic arthritis, rheumatoid arthritis, it is characterized in that: A, animal drugs are ground into coarse powder, soaked 1 hour, and added 6-10 times of decocting of medical material amount and boil each 1 hour 4 times; B, plant amedica are ground into coarse powder, soak 1 hour, add 6-10 times of decocting of medical material amount and boil each 1 hour 3 times; C, merge decoction liquor, be concentrated into the clear paste of relative density 1.08, cooling adds ethanol to containing alcohol amount 55%--75%, stirs, placed 24 hours, and filtration, Recycled ethanol gets thick paste; D, thick paste are made mixture or soft extract or granule or tablet or capsule with sucrose, dextrin, soluble starch.
9. according to claim 1,2,3,4,5,6 or 7 described a kind of preparation methoies for the treatment of the medicine of rheumatic arthritis, rheumatoid arthritis, it is characterized in that: A, pulverizing medicinal materials is become fine powder; B, fine powder add refined honey and make honeyed pill or water-honeyed pill, or add water and make the watered pill, or the encapsulated capsule of making of fine powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110213012.9A CN102885961B (en) | 2011-07-18 | 2011-07-18 | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110213012.9A CN102885961B (en) | 2011-07-18 | 2011-07-18 | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102885961A true CN102885961A (en) | 2013-01-23 |
| CN102885961B CN102885961B (en) | 2014-03-26 |
Family
ID=47529778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110213012.9A Active CN102885961B (en) | 2011-07-18 | 2011-07-18 | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102885961B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893442A (en) * | 2014-04-01 | 2014-07-02 | 周敏 | Traditional Chinese medicine medicament for treating rheumatic arthritis and preparation method thereof |
| CN105194248A (en) * | 2015-07-17 | 2015-12-30 | 柳培健 | Traditional Chinese medicine for treating arthritis |
| CN112717082A (en) * | 2021-02-23 | 2021-04-30 | 成都医学院 | Pharmaceutical composition for treating rheumatoid arthritis and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361923A (en) * | 2008-09-11 | 2009-02-11 | 周功庚 | Traditional Chinese medicine for treating rheumatism |
| CN101406646A (en) * | 2008-11-26 | 2009-04-15 | 路敦祥 | Chinese medicinal liquor for treating arthritis |
| CN101530566A (en) * | 2008-03-10 | 2009-09-16 | 王林祥 | Drug for treating rheumatism and rheumatoid disease |
-
2011
- 2011-07-18 CN CN201110213012.9A patent/CN102885961B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530566A (en) * | 2008-03-10 | 2009-09-16 | 王林祥 | Drug for treating rheumatism and rheumatoid disease |
| CN101361923A (en) * | 2008-09-11 | 2009-02-11 | 周功庚 | Traditional Chinese medicine for treating rheumatism |
| CN101406646A (en) * | 2008-11-26 | 2009-04-15 | 路敦祥 | Chinese medicinal liquor for treating arthritis |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893442A (en) * | 2014-04-01 | 2014-07-02 | 周敏 | Traditional Chinese medicine medicament for treating rheumatic arthritis and preparation method thereof |
| CN105194248A (en) * | 2015-07-17 | 2015-12-30 | 柳培健 | Traditional Chinese medicine for treating arthritis |
| CN112717082A (en) * | 2021-02-23 | 2021-04-30 | 成都医学院 | Pharmaceutical composition for treating rheumatoid arthritis and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102885961B (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100382815C (en) | Compound composition for treating arthralgia caused by wind-dampness and preparation thereof | |
| CN102240372A (en) | Medicine for treating gouty arthritis and hyperuricemia and preparation method thereof | |
| CN100382838C (en) | Chinese medicine for treating blood stagnation disease | |
| CN102058673A (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| CN1876157A (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN102885961B (en) | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine | |
| CN101417039B (en) | Medicine wine for treating gout | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102145127A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN101444581A (en) | Externally used Pain-removal plaster for curing arthralgia | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| CN102357191B (en) | Pharmaceutical composition for treating hashimoto disease | |
| CN108578603B (en) | Traditional Chinese medicine compound for treating kidney deficiency and marrow depletion type knee osteoarthritis based on shaoyang bone governing theory and application thereof | |
| CN1559486A (en) | Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia | |
| CN105497656A (en) | Efficient medicinal liquor for treating gout | |
| CN101590208B (en) | Medicament composition for treating rheumatoid arthritis, and preparation method thereof | |
| CN1839974B (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
| CN100441208C (en) | Bolus for treating rheumatic or rheumatoid arthritis and its preparation method | |
| CN103127358B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method | |
| CN103316133B (en) | Medicine for treating lame impediment | |
| CN101732606B (en) | Oral medicinal composition for treating psoriasis | |
| CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus | |
| CN100364596C (en) | Compounded mongolia medicine for treating diabetes and preparing method | |
| CN103381252B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A drug for treating rheumatoid arthritis and rheumatoid arthritis and its preparation method Effective date of registration: 20230828 Granted publication date: 20140326 Pledgee: Bank of China Limited Shaoyang Branch Pledgor: Hunan Province Xiangzhong Pharmaceutical Co.,Ltd. Registration number: Y2023980054088 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |